In the present study, 34 variants in the VEGFA, EDNRA, NBS1 and FAS genes were assessed in HNC patients (NPC vs. non-NPC), and the results from genotyping were correlated with clinical and pathological characteristics, as well as with survival outcome. The gene discussed is FAS; the disease is nasopharyngeal carcinoma.